This extensive clinical field trial was carried out with the main objective of evaluating the clinical safety and immunogenicity of YURVAC® RHD when administered to rabbits of 30 days of age under field conditions.
Evaluation of the safety and immunogenicity of YURVAC® RHD in rabbit kits under field conditions
Publications
Rabbits
The aim of this study was to assess whether YURVAC® RHD is safe
Download this article
Related products
Recombinant vaccine against rabbit haemorrhagic disease (RHD) caused by the classical (RHDV) and variant (RHDV2) strains, including highly virulent strains, in an emulsion for injection.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Inactivated vaccine against the variant strain of rabbit haemorrhagic disease (RHDV-2), in injectable emulsion.
Live heterologous vaccine against myxomatosis, in injectable freeze-dried tablet.
Live homologous vaccine against myxomatosis, in injectable freeze-dried tablet
Inactivated vaccine against the classic strain of rabbit haemorrhagic disease (RHDV1), in injectable emulsion
Enrofloxacin, in oral solution, animal medicine, animal medicines, medicine for rabbits, rabbit medicine, medicine for poultry
Related services
HIPRA University offers high quality training programmes in strategic areas of interest for professionals
Access an advanced diagnostic service with maximum comfort and reliability
